J. Molner AS
JML | Nasdaq Baltic
Overview
Corporate Details
- ISIN(s):
- EE3100109034
- LEI:
- 984500F0KEF52E642E45
- Country:
- Estonia
- Address:
- Akadeemia tee 21/5, 12618 Tallinn
- Website:
- https://www.jmolner.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Located in Northern Europe in Estonia, The J. Molner Company's main laboratory was originally founded in 2015 as part of a global pharmaceutical company to accelerate research and development activities. With a focus on sterile injectable and dermatological drugs for both the United States and Canada, our team has developed a GMP certified facility that provides services to pharmaceutical companies looking to grow their pipelines and manage costs by leveraging our capabilities.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Laboratorios Farmaceuticos Rovi S.A. | Spain | ROVI | |
|
Lavipharm S.A. | Greece | LAVI | |
|
Magle Chemoswed Holding AB | Sweden | MAGLE | |
|
Malin Corporation Plc | Ireland | MLC | |
|
Medika d.d. | Croatia | MDKA | |
|
Meditrina Cyprus Plc | Cyprus | MEDTR | |
|
Medivir | Sweden | MVIR | |
|
Mithra Pharmaceuticals S.A. | Belgium | MITRA | |
|
Moberg Pharma | Sweden | MOB | |
|
Molecular Partners AG | Switzerland | MOLN |